The following is a summary of “Cost–consequence analysis of early vs. delayed natalizumab use in highly active ...

While there’s no cure for multiple sclerosis (MS), there are many treatments ... to develop a treatment plan that addresses your medical issues and can help improve your physical symptoms ...

The rate of frailty among patients with multiple sclerosis (MS) ranges from 17% to 66% among ambulatory patients, and frailty among MS patients is linked to a host of complications. Read about the ...

If an employer fails to act, you can escalate the issue by seeking advice from ACAS (Advisory, Conciliation and Arbitration Service) or contacting a trade union if you are a member. Additionally, you ...

Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...

Medical experts can assess a person ... Botox is a valuable tool in the management of multiple sclerosis (MS), addressing key symptoms such as spasticity, bladder dysfunction, and pain.

Researchers don’t yet fully understand what causes multiple sclerosis (MS) but believe it may develop from a combination of genetic and environmental factors. Identifying these factors can help ...

Opens in a new tab or window "Medical Journeys" is a set of clinical ... It's clear that many of that group will also have multiple sclerosis (MS). Individuals with MS, therefore, may wonder ...

Ozanimod▼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

Cigna Group shares slumped after the health insurer reported cost pressures from surprisingly high catastrophic medical ...

Pregnant people with multiple sclerosis (MS) have a higher chance of experiencing mental illness both during their pregnancy and in the first years after they give birth than those without MS, ...